Key regions: United States, Brazil, Europe, Canada, United Kingdom
The Other OTC Pharmaceuticals market in G7 countries is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Customers in G7 countries have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the increasing awareness and acceptance of self-medication, and the desire for quick relief from common ailments. Additionally, the availability of a wide range of OTC pharmaceutical products catering to various health needs has also contributed to the growing customer preference for these products.
Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in G7 countries is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of synthetic drugs and are seeking alternative solutions. This has led to the rise of herbal and natural OTC pharmaceutical products, which are perceived as safer and more sustainable options. Another trend is the growing popularity of online retail channels for purchasing OTC pharmaceutical products. Customers are increasingly turning to e-commerce platforms to conveniently purchase these products and have them delivered to their doorstep.
Local special circumstances: Each G7 country has its own unique set of circumstances that influence the development of the Other OTC Pharmaceuticals market. For example, in the United States, the presence of a large aging population has contributed to the demand for OTC pharmaceutical products targeting age-related ailments such as joint pain and insomnia. In Japan, where the population is known for its longevity, there is a significant market for OTC pharmaceutical products that promote general health and well-being. Similarly, in Germany, the strong emphasis on natural and holistic healthcare has created a favorable environment for the growth of the herbal and natural OTC pharmaceutical segment.
Underlying macroeconomic factors: The growth of the Other OTC Pharmaceuticals market in G7 countries is also influenced by underlying macroeconomic factors. For instance, the increasing healthcare costs and the burden on healthcare systems have encouraged individuals to take greater responsibility for their own health. This has led to a shift towards self-medication and the use of OTC pharmaceutical products. Additionally, the rising disposable incomes in G7 countries have made these products more affordable and accessible to a larger population. The presence of well-established pharmaceutical companies and robust distribution networks also contributes to the growth of the market.In conclusion, the Other OTC Pharmaceuticals market in G7 countries is witnessing growth due to customer preferences for convenient and accessible healthcare solutions, trends such as the demand for natural and herbal remedies, local special circumstances that cater to specific health needs, and underlying macroeconomic factors that encourage self-medication and affordability.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
